Recent Cardiomyopathy Current Events | Cardiomyopathy News
|
|
|
Sort By:
Relevance | Page Views |
New methods found useful for diagnosing myocarditis
Myocarditis is an important, and often unrecognized cause of dilated cardiomyopathy (DCM). Several new diagnostic methods, such as cardiac magnetic resonance imaging (MRI), are useful for diagnosing myocarditis, according to a study published in the November 2009 issue of Mayo Clinic Proceedings. view more (2009-11-04)
UT Southwestern patient first in North Texas to receive newest-generation heart failure device
UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant. view more (2009-10-27)
MDC researchers prevent virus induced myocarditis
Life-threatening cardiac arrhythmia can be a consequence of myocarditis - an inflammation of the cardiac muscle that can be caused by the Coxsackievirus. view more (2009-04-03)
Extra 'STICH' in bypass adds no benefit to quality of life
A surgical procedure to resize an enlarged, weakened heart muscle during coronary bypass surgery for heart failure adds cost and risk but doesn't offer patients any additional benefit when compared with those who received bypass procedure alone, according to researchers from the Duke Clinical Research Institute (DCRI). view more (2009-03-30)
New potential therapeutic target discovered for genetic disorder -- Barth syndrome
Researchers at NYU Langone Medical Center may have discovered a new targeted intervention for Barth Syndrome (BTHS). BTHS, a sometimes fatal disease, is a serious genetic disorder occurring predominantly in males that leads to infection or heart failure in childhood. view more (2009-03-03)
Studies point to novel target for treating arrhythmias
Abnormal heart rhythms - arrhythmias - are killers. They strike without warning, causing sudden cardiac death, which accounts for about 10 percent of all deaths in the United States. view more (2009-01-22)
The heart disease mutation carried by 60 million
Heart disease is the number one killer in the world and India carries more than its share of this burden. Moreover, the problem is set to rise: it is predicted that by 2010 India's population will suffer approximately 60% of the world's heart disease. view more (2009-01-20)
Safe new therapy for genetic heart disease
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease. view more (2008-12-30)
Fruit fly research may lead to better understanding of human heart disease
Researchers at the Burnham Institute for Medical Research (Burnham) have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function. The study, led by Rolf Bodmer, Ph.D., was published in Proceedings of National Academy of Sciences. view more (2008-12-02)
First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure. view more (2008-11-18)
Research uncovers new steps on pathway to enlarged heart
Researchers have new insight into the mechanisms that underlie a pathological increase in the size of the heart. The research, published by Cell Press in the October 24th issue of the journal Molecular Cell, may lead to the development of new strategies for managing this extremely common cardiac ailment that often leads to heart failure. view more (2008-10-24)
The risk factors of idiopathic pulmonary fibrosis in HCV patients
Hepatitis C virus (HCV) is one of the more common causes of chronic liver disease in world with a variety of extrahepatic complications such as essential mixed cryoglobulinemia, membranoproliferative glomerulonep hritis, autoimmune thyroiditis, sialadenitis, and cardiomyopathy. view more (2008-10-23)
Stem cell regeneration repairs congenital heart defect
Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. view more (2008-09-12)
Sports-related sudden cardiac death is reduced by pre-participation cardiovascular screening
Young competitive athletes are perceived by the general population to be the healthiest members of society. The possibility that highly trained athletes may have a potentially serious cardiac condition that can predispose to life-threatening tachyarrhythmias or sudden cardiac death seems paradoxical. view more (2008-09-02)
Should we use echocardiography to screen young athletes?
Sudden and unexpected deaths in young competitive athletes are uncommon but highly visible events, which raise concern and ethical issues in both the lay public and medical community. view more (2008-09-02)
Alcohol consumption declining, according to results of new study
Overall alcohol use-particularly consumption of beer-is declining in the US, according to a new study published in the August 2008 issue of The American Journal of Medicine. view more (2008-08-06)
Scientists identify genomic 'fingerprint' for alcohol-induced heart failure
A person with dilated cardiomyopathy has an enlarged and stretched heart cavity, usually too weak to pump normally; most people will go on to develop heart failure. view more (2008-05-05)
A search for protection against chemotherapy cardiotoxicity
Researchers at the University of Grenoble, in France, have discovered that erythropoietin administration prevents acute cardiotoxic effects induced by doxorubicin and trastuzumab exposures. view more (2007-12-21)
Genes identified that protect against heart damage from chemotherapy
A series of genes that protect cells from the powerful, common chemotherapeutic agent doxorubicin has been identified by researchers working to understand how the drug also can destroy the heart. view more (2007-12-04)
The Structural Basis of Familial Hypertrophic Cardiomyopathy is Revealed
Familial Hypertrophic Cardiomyopathy (FHC), the leading cause of sudden death in athletes and young people, is a genetic disorder of the heart that is characterized by an increased thickness in tissue of the left ventricle. view more (2007-11-12)
|
|
|
|
Sort By:
Relevance | Page Views |
|
